Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Pulmonary function testing prior to hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 35, pages 429–435 (2005)Cite this article

Summary:

The pretransplant pulmonary function test plays an important role in the management of noninfectious pulmonary complications after hematopoietic stem cell transplantation (HCT). Although these tests are widely used as standard preoperative assessments in the nontransplant population, common conditions associated with the HCT patient requires that particular attention be given to interpretation of pulmonary function testing (PFT) results, such as comparison of serial pulmonary function tests and evaluation of the diffusion capacity. Although their utility in helping to predict the likelihood of developing post transplant pulmonary complications and mortality is not well established, current data indicate that pretransplant PFTs are important as a reference for the interpretation of post transplant PFTs and for identifying patients at high risk for developing pulmonary complications and/or mortality after HCT. Future studies of pretransplant pulmonary function should consider the advances in HCT, so that pretransplant PFTs will become a useful tool in pretransplant risk assessment and help the transplant oncologist to determine the most appropriate conditioning regimen for a patient with compromised lung function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Patriarca F, Skert C, Sperotto A et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant 2004; 33: 751–758.

    Article  CAS  PubMed  Google Scholar 

  2. Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.

    Article  CAS  PubMed  Google Scholar 

  3. Gopal R, Ha CS, Tucker SL et al. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity. Cancer 2001; 92: 1949–1958.

    Article  CAS  PubMed  Google Scholar 

  4. Ozsahin M, Pene F, Touboul E et al. Total-body irradiation before bone marrow transplantation. Results of two randomized instantaneous dose rates in 157 patients. Cancer 1992; 69: 2853–2865.

    Article  CAS  PubMed  Google Scholar 

  5. Szekely J, Fabry L, Forgacs G et al. Total body irradiation before bone marrow transplantation. Technique and acute toxicity. Strahlenther Onkol 1999; 175: 606–610.

    Article  CAS  PubMed  Google Scholar 

  6. Kader HA, Khanna S, Hutchinson RM et al. Pulmonary complications of bone marrow transplantation: the impact of variations in total body irradiation parameters. Clin Oncol (R Coll Radiol) 1994; 6: 96–101.

    Article  CAS  Google Scholar 

  7. Rossi SE, Erasmus JJ, McAdams HP et al. Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000; 20: 1245–1259.

    Article  CAS  PubMed  Google Scholar 

  8. Helman Jr DL, Byrd JC, Ales NC, Shorr AF . Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. Chest 2002; 122: 785–790.

    Article  PubMed  Google Scholar 

  9. Ozsahin M, Belkacemi Y, Pene F et al. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation. Int J Radiat Oncol Biol Phys 1996; 34: 71–77.

    Article  CAS  PubMed  Google Scholar 

  10. Malik SW, Myers JL, DeRemee RA, Specks U . Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 1996; 154: 1851–1856.

    Article  CAS  PubMed  Google Scholar 

  11. Gulbahce HE, Manivel JC, Jessurun J . Pulmonary cytolytic thrombi: a previously unrecognized complication of bone marrow transplantation. Am J Surg Pathol 2000; 24: 1147–1152.

    Article  CAS  PubMed  Google Scholar 

  12. Hackman RC, Madtes DK, Petersen FB, Clark JG . Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation 1989; 47: 989–992.

    Article  CAS  PubMed  Google Scholar 

  13. Williams LM, Fussell S, Veith RW et al. Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature. Chest 1996; 109: 1388–1391.

    Article  CAS  PubMed  Google Scholar 

  14. Mathew P, Bozeman P, Krance RA et al. Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 221–223.

    CAS  PubMed  Google Scholar 

  15. Thirman MJ, Devine SM, O'Toole K et al. Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 10: 307–311.

    CAS  PubMed  Google Scholar 

  16. Kleinau I, Perez-Canto A, Schmid HJ et al. Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 841–844.

    Article  CAS  PubMed  Google Scholar 

  17. Kanda Y, Takahashi T, Imai Y et al. Bronchiolitis obliterans organizing pneumonia after syngeneic bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 1997; 19: 1251–1253.

    Article  CAS  PubMed  Google Scholar 

  18. Silliman CC, Paterson AJ, Dickey WO et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997; 37: 719–726.

    Article  CAS  PubMed  Google Scholar 

  19. Silliman CC, Boshkov LK, Mehdizadehkashi Z et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454–462.

    Article  CAS  PubMed  Google Scholar 

  20. Weiner RS, Dicke KA . Risk factors for interstitial pneumonitis following allogeneic bone marrow transplantation for severe aplastic anemia: a preliminary report. Transplant Proc 1987; 19: 2639–2642.

    CAS  PubMed  Google Scholar 

  21. Wingard JR, Mellits ED, Sostrin MB et al. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution. Medicine (Baltimore) 1988; 67: 175–186.

    Article  CAS  Google Scholar 

  22. Wingard JR, Sostrin MB, Vriesendorp HM et al. Interstitial pneumonitis following autologous bone marrow transplantation. Transplantation 1988; 46: 61–65.

    Article  CAS  PubMed  Google Scholar 

  23. Crawford SW, Hackman RC . Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1393–1400.

    Article  CAS  PubMed  Google Scholar 

  24. Crawford SW, Longton G, Storb R . Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993; 12: 225–231.

    CAS  PubMed  Google Scholar 

  25. Robbins RA, Linder J, Stahl MG et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 1989; 87: 511–518.

    Article  CAS  PubMed  Google Scholar 

  26. Wojno KJ, Vogelsang GB, Beschorner WE, Santos GW . Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease. Transplantation 1994; 57: 88–92.

    Article  CAS  PubMed  Google Scholar 

  27. Lewis ID, DeFor T, Weisdorf DJ . Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy. Bone Marrow Transplant 2000; 26: 539–543.

    Article  CAS  PubMed  Google Scholar 

  28. Afessa B, Tefferi A, Litzow MR, Peters SG . Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166: 1364–1368.

    Article  PubMed  Google Scholar 

  29. Clark JG, Crawford SW, Madtes DK, Sullivan KM . Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368–376.

    Article  CAS  PubMed  Google Scholar 

  30. Clark JG, Schwartz DA, Flournoy N et al. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107: 648–656.

    Article  CAS  PubMed  Google Scholar 

  31. Curtis DJ, Smale A, Thien F et al. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 169–173.

    CAS  PubMed  Google Scholar 

  32. Wyatt SE, Nunn P, Hows JM et al. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax 1984; 39: 887–894.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Philit F, Wiesendanger T, Archimbaud E et al. Post-transplant obstructive lung disease (‘bronchiolitis obliterans’): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 1995; 8: 551–558.

    CAS  PubMed  Google Scholar 

  34. Chien JW, Martin PJ, Flowers ME et al. Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 33: 759–764.

    Article  CAS  PubMed  Google Scholar 

  35. Chien JW, Martin PJ, Gooley TA et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208–214.

    Article  PubMed  Google Scholar 

  36. Ostrow D, Buskard N, Hill RS et al. Bronchiolitis obliterans complicating bone marrow transplantation. Chest 1985; 87: 828–830.

    Article  CAS  PubMed  Google Scholar 

  37. Holland HK, Wingard JR, Beschorner WE et al. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988; 72: 621–627.

    CAS  PubMed  Google Scholar 

  38. Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ . Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9: 657–666.

    Article  PubMed  Google Scholar 

  39. Freudenberger TD, Madtes DK, Curtis JR et al. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003; 102: 3822–3828.

    Article  CAS  PubMed  Google Scholar 

  40. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107–1136.

  41. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991; 144: 1202–1218.

  42. McFadden Jr ER, Linden DA . A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med 1972; 52: 725–737.

    Article  PubMed  Google Scholar 

  43. Cosio M, Ghezzo H, Hogg JC et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978; 298: 1277–1281.

    Article  CAS  PubMed  Google Scholar 

  44. McCarthy DS, Craig DB, Cherniack RM . Intraindividual variability in maximal expiratory flow-volume and closing volume in asymptomatic subjects. Am Rev Respir Dis 1975; 112: 407–411.

    CAS  PubMed  Google Scholar 

  45. Cochrane GM, Prieto F, Clark TJ . Intrasubject variability of maximal expiratory flow volume curve. Thorax 1977; 32: 171–176.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Parimon T, Clark JG, Chien JW . Implication of significant bronchodilator response in patients who develop airflow obstruction after hematopoietic stem cell transplant. Am J Respir Crit Care Med 2004; 169: A93.

    Google Scholar 

  47. Cliff IJ, Evans AH, Pantin CF, Baldwin DR . Comparison of two new methods for the measurement of lung volumes with two standard methods. Thorax 1999; 54: 329–333.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Blakemore WS, Forster RE, Morton JW, Ogilvie CM . A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957; 36: 1–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique – 1995 update. Am J Respir Crit Care Med 1995; 152: 2185–2198.

  50. Crapo RO, Forster II RE . Carbon monoxide diffusing capacity. Clin Chest Med 1989; 10: 187–198.

    CAS  PubMed  Google Scholar 

  51. Yamaguchi K, Mori M, Kawai A et al. Inhomogeneities of ventilation and the diffusing capacity to perfusion in various chronic lung diseases. Am J Respir Crit Care Med 1997; 156: 86–93.

    Article  CAS  PubMed  Google Scholar 

  52. Punjabi NM, Shade D, Patel AM, Wise RA . Measurement variability in single-breath diffusing capacity of the lung. Chest 2003; 123: 1082–1089.

    Article  PubMed  Google Scholar 

  53. Clausen J, Crapo RO, Gardner RM . Interlaboratory comparisons of pulmonary function testing. Am Rev Respir Dis 1984; 129 (Suppl): A37.

    Google Scholar 

  54. Cotes JE, Dabbs JM, Elwood PC et al. Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 1972; 42: 325–335.

    Article  CAS  PubMed  Google Scholar 

  55. Stam H, Splinter TA, Versprille A . Evaluation of diffusing capacity in patients with a restrictive lung disease. Chest 2000; 117: 752–757.

    Article  CAS  PubMed  Google Scholar 

  56. do Pico GA, Wiley Jr AL, Rao P, Dickie HA . Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease. Chest 1979; 75: 688–692.

    Article  CAS  PubMed  Google Scholar 

  57. Badier M, Guillot C, Delpierre S et al. Pulmonary function changes 100 days and one year after bone marrow transplantation. Bone Marrow Transplant 1993; 12: 457–461.

    CAS  PubMed  Google Scholar 

  58. Gore EM, Lawton CA, Ash RC, Lipchik RJ . Pulmonary function changes in long-term survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 1996; 36: 67–75.

    Article  CAS  PubMed  Google Scholar 

  59. Ghalie R, Szidon JP, Thompson L et al. Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant pulmonary function tests. Bone Marrow Transplant 1992; 10: 359–365.

    CAS  PubMed  Google Scholar 

  60. Schwarer AP, Hughes JM, Trotman-Dickenson B et al. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation 1992; 54: 1002–1008.

    Article  CAS  PubMed  Google Scholar 

  61. Matute-Bello G, McDonald GD, Hinds MS et al. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation. Bone Marrow Transplant 1998; 21: 1125–1130.

    Article  CAS  PubMed  Google Scholar 

  62. Crawford SW, Fisher L . Predictive value of pulmonary function tests before marrow transplantation. Chest 1992; 101: 1257–1264.

    Article  CAS  PubMed  Google Scholar 

  63. Burrows B, Bloom JW, Traver GA, Cline MG . The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987; 317: 1309–1314.

    Article  CAS  PubMed  Google Scholar 

  64. Goldberg SL, Klumpp TR, Magdalinski AJ, Mangan KF . Value of the pretransplant evaluation in predicting toxic day-100 mortality among blood stem-cell and bone marrow transplant recipients. J Clin Oncol 1998; 16: 3796–3802.

    Article  CAS  PubMed  Google Scholar 

  65. Niederwieser D, Maris M, Shizuru JA et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101: 1620–1629.

    Article  CAS  PubMed  Google Scholar 

  66. McSweeney PA, Niederwieser D, Shizuru JA et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390–3400.

    Article  CAS  PubMed  Google Scholar 

  67. Maris MB, Niederwieser D, Sandmaier BM et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003; 102: 2021–2030.

    Article  CAS  PubMed  Google Scholar 

  68. Fukuda T, Hackman RC, Guthrie KA et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003; 102: 2777–2785.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was financially supported by 1R01 HL71914-01, 1K23HL69860-01, American Lung Association of Washington Research Grant, and the Amy Strelzer Manasevit Research Award from the National Marrow Donor Program.

Author information

Authors and Affiliations

  1. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    J W Chien, D K Madtes & J G Clark

  2. Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA

    J W Chien, D K Madtes & J G Clark

Authors
  1. J W Chien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D K Madtes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J G Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J W Chien.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chien, J., Madtes, D. & Clark, J. Pulmonary function testing prior to hematopoietic stem cell transplantation. Bone Marrow Transplant 35, 429–435 (2005). https://doi.org/10.1038/sj.bmt.1704783

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704783

This article is cited by

Search

Advanced search

Quick links